Status:
COMPLETED
MSOT_PI Analysis of Revascularization Procedure Using Optoacoustic Imaging
Lead Sponsor:
University Hospital Erlangen
Conditions:
PAD
Vascular Diseases
Eligibility:
All Genders
18+ years
Brief Summary
The aim of the proposed study is to analyse the improvement of the calf muscle perfusion of patients with PAD Fontaine stage II and critical limb threatheaning ischemia (CLTI) after endovascular and s...
Detailed Description
Since 2021, the University Hospital Erlangen (department of pediatrics) disposes of a CE-certified multispectral optoacoustic tomograph (MSOT). Similar to sonography, the MSOT technology allows for no...
Eligibility Criteria
Inclusion
- Diagnosis of PAD confirmed by clinical examination and ABI (ABI ≤ 0.90)
- Planned for elective revascularization therapy
- Able to provide informed consent
- PAD stages II-IV Fontaine
- Age of \> 18 years
Exclusion
- Severe comorbid conditions
- Non-PAD related walking impairments (e.g., neurological disorders)
- Inability to comply with study protocols
- PAD stage I
- Age of \< 18 years
Key Trial Info
Start Date :
March 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06966297
Start Date
March 1 2024
End Date
March 1 2025
Last Update
May 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Erlangen
Erlangen, Bavaria, Germany, 91054